AFP and hepatocellular carcinoma: In this study, we sought to evaluate the diagnostic accuracy of serum GPC3 levels for HCC (especially AFP-negative and early-stage HCC), and to generate a new model by combining GPC3 with other biomarkers to increase the accuracy of early-stage HCC diagnosis and thus improve the survival prognosis of patients.